Conducted; negative (Ames, CHO chromosomal aberration, mouse micronucleus)
“Golodirsen was negative in an adequately conducted standard battery of in vitro (Ames, chromosomal aberration in CHO cells) and in vivo (mouse bone marrow micronucleus) assays.”
✓ VerifiedFDA pharmacology/toxicology review, p. 8Source ↗
Carcinogenicity
Not conducted pre-approval; dose-ranging done; Tg mouse and 2-year rat as PMRs
“No carcinogenicity studies have been conducted. The sponsor has conducted dose-ranging (DR) studies (reviewed below) to support planned carcinogenicity studies.”
✓ VerifiedFDA pharmacology/toxicology review, p. 7Source ↗
Reproductive & developmental
Not conducted (almost exclusively male population); male reproductive assessments and juvenile rat study
“No developmental and reproductive toxicity studies were conducted with golodirsen because the patient population is almost entirely male.”
✓ VerifiedFDA pharmacology/toxicology review, p. 2Source ↗
Safety pharmacology
Standalone telemetered monkey CV/CNS study (Latin square, up to 320 mg/kg IV) plus hERG; no effects
“In the only in vivo safety pharmacology study, golodirsen (0, 5, 40, or 320 mg/kg IV) had no effects on CNS, cardiovascular, or respiratory parameters in four male cynomolgus monkeys.”
✓ VerifiedFDA pharmacology/toxicology review, p. 5Source ↗